Shu‐Fen Peng
- Molecular Biology top 5%
- Biomaterials top 2%
- Pharmaceutical Science top 0.5%
- Cancer Research top 10%
- Plant Science top 10%
- Co-authors
- Hsing‐Wen SungJing‐Gung ChungJai‐Sing YangFwu‐Long MiYi‐Cheng HoYu-Hsin LinMichael T. TsengHsin‐Lung Chen
- Topics
- RNA Interference and Gene Delivery (20 papers)Genomics, phytochemicals, and oxidative stress (15 papers)Cell death mechanisms and regulation (13 papers)
- Journals
- SHILAP Revista de lepidopterologíaBiomaterialsGenetics
- Partner nations
- TaiwanJapanUnited States
In The Last Decade
Shu‐Fen Peng
108 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 1.8k
- Biomaterials 537
- Pharmaceutical Science 416
- Cancer Research 307
- Plant Science 306
Countries citing papers authored by Shu‐Fen Peng
This map shows the geographic impact of Shu‐Fen Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Fen Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Fen Peng more than expected).
Fields of papers citing papers by Shu‐Fen Peng
This network shows the impact of papers produced by Shu‐Fen Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Fen Peng. The network helps show where Shu‐Fen Peng may publish in the future.
Co-authorship network of co-authors of Shu‐Fen Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Fen Peng. A scholar is included among the top collaborators of Shu‐Fen Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Fen Peng. Shu‐Fen Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 13 | |
| 6 | 6 | |
| 7 | 10 | |
| 8 | 5 | |
| 9 | 11 | |
| 10 | 4 | |
| 11 | The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells | 2 |
| 12 | 20 | |
| 13 | 34 | |
| 14 | 7 | |
| 15 | 62 | |
| 16 | 36 | |
| 17 | 13 | |
| 18 | 83 | |
| 19 | 74 | |
| 20 | 21 |
About Shu‐Fen Peng
Shu‐Fen Peng is a scholar working on Molecular Medicine, Toxicology and Cancer Research, having authored 109 papers that have together received 3.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (20 papers), Genomics, phytochemicals, and oxidative stress (15 papers) and Cell death mechanisms and regulation (13 papers). The work is most often cited by research in Pharmaceutical Science (416 citations), Molecular Medicine (294 citations) and Biomaterials (537 citations). Shu‐Fen Peng has collaborated with scholars based in Taiwan, Japan and United States. Frequent co-authors include Hsing‐Wen Sung, Jing‐Gung Chung, Jai‐Sing Yang, Fwu‐Long Mi, Yi‐Cheng Ho, Yu-Hsin Lin, Michael T. Tseng, Hsin‐Lung Chen, Ming-Cheng Wei and Chiung-Tong Chen. Their work appears in journals such as SHILAP Revista de lepidopterología, Biomaterials and Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.